
Implicity® is a digital MedTech company - founded by cardiac electrophysiologist Arnaud Rosier MD - that provides a universal cardiac remote monitoring and research platform to hospitals and clinics - helping them provide the best remote care to cardiac patients. Implicity develops unique AI and knowledge-based algorithms with the potential to predict patient health status, reducing healthcare professionals' workload. The Implicity platform aggregates, normalizes, and standardizes data from all implantable cardiac electronic devices across all major manufacturers - and improves care for patients with chronic heart failure conditions. Implicity proudly protects over 100,000 patients in more than 250 medical facilities across the United States and Europe. www.implicity.com

Implicity® is a digital MedTech company - founded by cardiac electrophysiologist Arnaud Rosier MD - that provides a universal cardiac remote monitoring and research platform to hospitals and clinics - helping them provide the best remote care to cardiac patients. Implicity develops unique AI and knowledge-based algorithms with the potential to predict patient health status, reducing healthcare professionals' workload. The Implicity platform aggregates, normalizes, and standardizes data from all implantable cardiac electronic devices across all major manufacturers - and improves care for patients with chronic heart failure conditions. Implicity proudly protects over 100,000 patients in more than 250 medical facilities across the United States and Europe. www.implicity.com
Sector: MedTech — remote cardiac monitoring
Product: AI-powered, manufacturer-agnostic platform for implantable cardiac device data aggregation and triage
Regulatory: FDA-cleared AI algorithms (including a 510(k) in 2024 for a heart-failure prediction algorithm)
Headquarters: Paris, France (with U.S. office in Cambridge, MA)
Scale: Protects >100,000 patients across >250 medical facilities
Funding: Reported total funding ~USD 30.7M; Series A announced Apr 27, 2022 (~$23M)
Remote cardiac monitoring and management of patients with implantable cardiac electronic devices and chronic heart failure.
2016
Hospitals and Health Care
23000000
Additional participants reported: BNP Paribas Développement, Serena, XAnge, Karista
| Company |
|---|